Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT

PURPOSE: A recent phase III study (PARAMOUNT) demonstrated that pemetrexed continuation maintenance therapy is a new treatment paradigm for advanced nonsquamous non-small cell lung cancer (NSCLC). The majority of patients enrolled in PARAMOUNT were Caucasian (94%). We reviewed efficacy and safety da...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, James Chin-Hsin, Ahn, Myung-Ju, Nakagawa, Kazuhiko, Tamura, Tomohide, Barraclough, Helen, Enatsu, Sotaro, Cheng, Rebecca, Orlando, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506102/
https://www.ncbi.nlm.nih.gov/pubmed/25410761
http://dx.doi.org/10.4143/crt.2013.266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506102/
https://www.ncbi.nlm.nih.gov/pubmed/25410761
http://dx.doi.org/10.4143/crt.2013.266

Ejemplares similares